Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Drugs

Retrieve available abstracts of 7 articles:
HTML format
Text format



Single Articles


    January 2018
  1. BERMEJO F, Guerra I, Algaba A, Lopez-Sanroman A, et al
    Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease.
    Drugs. 2018;78:1-18.
    PubMed     Text format     Abstract available


    July 2017
  2. LAMB YN, Duggan ST
    Ustekinumab: A Review in Moderate to Severe Crohn's Disease.
    Drugs. 2017;77:1105-1114.
    PubMed     Text format     Abstract available


    May 2017
  3. FLAMANT M, Rigaill J, Paul S, Roblin X, et al
    Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects.
    Drugs. 2017 May 18. doi: 10.1007/s40265-017-0755.
    PubMed     Text format     Abstract available


    March 2017
  4. HINDRYCKX P, Novak G, Vande Casteele N, Khanna R, et al
    Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
    Drugs. 2017 Mar 1. doi: 10.1007/s40265-017-0719.
    PubMed     Text format    


    February 2017
  5. HINDRYCKX P, Novak G, Vande Casteele N, Khanna R, et al
    Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
    Drugs. 2017 Feb 23. doi: 10.1007/s40265-017-0693.
    PubMed     Text format     Abstract available


    January 2017
  6. BOAL CARVALHO P, Cotter J
    Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.
    Drugs. 2017 Jan 11. doi: 10.1007/s40265-016-0676.
    PubMed     Text format     Abstract available


    September 2016
  7. GECSE KB, Lakatos PL
    Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects.
    Drugs. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: